Ciliary function of the nose in patients with Osler's disease and the effect of topically applied estrogens as a nose ointment

Rhinology

Volumn 49, Issue 4, 2011, Pages 5-

  Ulrich Sommer, J ^a   Stuck, Boris A ^a   Heiser, Clemens ^a   Kassner, Stefan S ^a   Hormann K ^a   Sadick, Haneen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CBF; Cilia; Estriol; HHT; Morbus Osler

Indexed keywords

ESTRIOL;

ADULT; ARTICLE; DRUG EFFECT; EUKARYOTIC FLAGELLUM; FEMALE; HUMAN; MALE; MIDDLE AGED; NOSE; OINTMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RENDU OSLER WEBER DISEASE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; CILIA; ESTRIOL; FEMALE; HUMANS; MALE; MIDDLE AGED; NOSE; OINTMENTS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 80054716170     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino11.046     Document Type: Article

References (43)

1. Chapman KR, Allen LJ, Romet TT. Pulmonary function in normal subjects following exercise at cold ambient temperatures. Eur J Appl Physiol Occup Physiol. 1990; 60: 228-232.
2. Satir P, Sleigh MA. The physiology of cilia and mucociliary interactions. Annu Rev Physiol. 1990; 52: 137-155.
3. Hilfinger A, Chattopadhyay AK, Julicher F. Nonlinear dynamics of cilia and flagella. Phys Rev E Stat Nonlin Soft Matter Phys. 2009; 79(5 Pt 1): 051918.
4. Stannard W, O'Callaghan C. Ciliary function and the role of cilia in clearance. J Aerosol Med. 2006; 19: 110-115.
5. Jorissen M, Bessems A. Influence of culture duration and ciliogenesis on the relationship between ciliary beat frequency and temperature in nasal epithelial cells. Eur Arch Otorhinolaryngol. 1995; 252: 451-454.
6. Shah AS, Ben-Shahar Y, Moninger TO, Kline JN, Welsh MJ. Motile cilia of human airway epithelia are chemosensory. Science. 2009; 28; 325(5944): 1131-1134.
7. Chen B, Shaari J, Claire SE, et al. Altered sinonasal ciliary dynamics in chronic rhinosinusitis. Am J Rhinol. 2006; 20: 325-329.
8. Elliott MK, Sisson JH, Wyatt TA. Effects of cigarette smoke and alcohol on ciliated tracheal epithelium and inflammatory cell recruitment. Am J Respir Cell Mol Biol. 2007; 36: 452-459.
9. Sommer JU, Schafer K, Omran H, et al. ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities. Eur Arch Otorhinolaryngol. 2011; 268(3): 383-388.
10. Weber FP. Multiple Hereditary Developmental Angeiomata (Telangiectases), with Recurring Haemorrhages. Proc R Soc Med. 1908; 1(Laryngol Sect): 43-44.
11. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bulletin of the Johns Hopkins Hospital. 1901; 12: 7.
12. Rendu H. Epistaxis repetees chez un sujet porteur de petits angiomes cutanes et muquez. Gazette des Hopitaux Civils et Militaires (Paris). 1896; 135: 3.
13. Braverman IM, Keh A, Jacobson BS. Ultrastructure and threedimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol. 1990; 95: 422-427.
14. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011; 14.
15. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000; 91: 66-67.
16. Bergler W, Riedel F, Baker-Schreyer A, Juncker C, Hormann K. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope. 1999; 109: 15-20.
17. Zohar Y, Sadov R, Shvili Y, Talmi Y, Laurian N. Surgical management of epistaxis in hereditary hemorrhagic telangiectasia. Arch Otolaryngol Head Neck Surg. 1987; 113: 754-757.
18. Werner JA, Lippert BM, Geisthoff UW, Rudert H. Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia. Laryngorhinootologie. 1997; 76: 495-501.
19. Fiorella ML, Ross D, Henderson KJ, White RI, Jr. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Laryngoscope. 2005; 115: 301-305.
20. Saunders WH. Septal dermoplasty for hereditary telangiectasia and other conditions. Otolaryngol Clin North Am. 1973; 6: 745-755.
21. Fischer M, Dietrich U, Labisch C, Zanella FE, Jahnke K. Critical evaluation of vascular embolization in patients with Rendu-Osler disease. Laryngorhinootologie. 1997; 76: 490-494.
22. Lund VJ, Howard DJ. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol. 1997; 111: 30-33.
23. Klepfish A, Berrebi A, Schattner A. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia. Arch Intern Med. 2001; 12; 161: 767.
24. Bergler W, Sadick H, Gotte K, Riedel F, Hormann K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol. 2002; 111(3 Pt 1): 222-228.
25. Sadick H, Riedel F, Oulmi J, Hormann K, Bergler WF. Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa. HNO. 2003; 51: 118-124.
26. Sadick H, Bergler WF, Oulmi-Kagermann J, et al. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia. Arch Med Res. 2005; 36: 468-473.
27. Proctor DF, Adams GK, Andersen I, Man SF. Nasal mucociliary clearance in man. Ciba Found Symp. 1978: 219-234.
28. Andersen I, Proctor DF. Measurement of nasal mucociliary clearance. Eur J Respir Dis Suppl. 1983; 127: 37-40.
29. Sommer JU, Gross S, Hormann K, Stuck BA. Timedependent changes in nasal ciliary beat frequency. Eur Arch Otorhinolaryngol. 2010; 267: 1383-1387.
30. Rollin M, Seymour K, Hariri M, Harcourt J. Rhinosinusitis, symptomatology and absence of polyposis in children with primary ciliary dyskinesia. Rhinology. 2009; 47: 75-78.
31. Sommer JU, Gross S, Hormann K, Stuck BA. Timedependent changes in nasal ciliary beat frequency. Eur Arch Otorhinolaryngol. 2010; 267: 1383-1387.
32. Thomas B, Rutman A, O'Callaghan C. Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia. Eur Respir J. 2009; 34: 401-404.
33. Sisson JH, Stoner JA, Ammons BA, Wyatt TA. All-digital image capture and whole-field analysis of ciliary beat frequency. J Microsc. 2003; 211: 103-111.
34. R-Development-Core-Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
35. Beule AG, Weber RK, Kaftan H, Hosemann W. Review: pathophysiology and methodology of nasal packing. Laryngorhinootologie. 2004; 83: 534-551; quiz 53-56.
36. Ferri E, Ianniello F, Armato E, Cavaleri S, Capuzzo P. The application of argon plasma coagulation (APC) in surgical treatment of inferior turbinates. Acta Otorhinolaryngol Ital. 2002; 22: 220-226.
37. Schrodter S, Biermann E, Halata Z. Histological evaluation of age-related changes in human respiratory mucosa of the middle turbinate. Anat Embryol. (Berl). 2003; 207: 19-27.
38. Dimova S, Maes F, Brewster ME, Jorissen M, Noppe M, Augustijns P. High-speed digital imaging method for ciliary beat frequency measurement. J Pharm Pharmacol. 2005; 57: 521-526.
39. Button B, Boucher RC. Role of mechanical stress in regulating airway surface hydration and mucus clearance rates. Respir Physiol Neurobiol. 2008; 163: 189-201.
40. Tarran R, Grubb BR, Gatzy JT, Davis CW, Boucher RC. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J Gen Physiol. 2001; 118: 223-236.
41. Duchateau GS, Graamans K, Zuidema J, Merkus FW. Correlation between nasal ciliary beat frequency and mucus transport rate in volunteers. Laryngoscope. 1985; 95: 854-859.
42. Cignarella A, Paoletti R, Puglisi L. Direct effects of estrogen on the vessel wall. Med Res Rev. 2001; 21: 171-184.
43. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial. Acta Med Scand. 1981; 209: 393-396.